The proper concentrations of dextrose and lidocaine in regenerative injection therapy: in vitro study
Open Access
- 1 September 2021
- journal article
- research article
- Published by Korean Pain Society in The Korean Journal of Pain
- Vol. 34 (1), 19-26
- https://doi.org/10.3344/kjp.2021.34.1.19
Abstract
Background: Prolotherapy is a proliferation therapy as an alternative medicine. A combination of dextrose solution and lidocaine is usually used in prolotherapy. The concentrations of dextrose and lidocaine used in the clinical field are very high (dextrose 10%-25%, lidocaine 0.075%-1%). Several studies show about 1% dextrose and more than 0.2% lidocaine induced cell death in various cell types. We investigated the effects of low concentrations of dextrose and lidocaine in fibroblasts and suggest the optimal range of concentrations of dextrose and lidocaine in prolotherapy. Methods: Various concentrations of dextrose and lidocaine were treated in NIH-3T3. Viability was examined with trypan blue exclusion assay and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Migration assay was performed for measuring the motile activity. Extracellular signal-regulated kinase (Erk) activation and protein expression of collagen I and alpha-smooth muscle actin (alpha-SMA) were determined with western blot analysis. Results: The cell viability was decreased in concentrations of more than 5% dextrose and 0.1% lidocaine. However, in the concentrations 1% dextrose (D1) and 0.01% lidocaine (L0.01), fibroblasts proliferated mildly. The ability of migration in fibroblast was increased in the D1, L0.01, and D1 + L0.01 groups sequentially. D1 and L0.01 increased Erk activation and the expression of collagen I and alpha-SMA and D1 + L0.01 further increased. The inhibition of Erk activation suppressed fibroblast proliferation and the synthesis of collagen I. Conclusions: D1, L0.01, and the combination of D1 and L0.01 induced fibroblast proliferation and increased collagen I synthesis via Erk activation.Funding Information
- National Research Foundation of Korea (NRF-2011-0021216)
This publication has 26 references indexed in Scilit:
- Local Anesthetics Induce Apoptosis in Human Thyroid Cancer Cells through the Mitogen-Activated Protein Kinase PathwayPLOS ONE, 2014
- ERK2 small interfering RNAs prevent epidural fibrosis via the efficient inhibition of collagen expression and inflammation in laminectomy ratsBiochemical and Biophysical Research Communications, 2014
- Local Anesthetics Induce Apoptosis in Human Breast Tumor CellsAnesthesia & Analgesia, 2014
- Lidocaine treatment during synapse reformation periods permanently inhibits NGF-induced excitation in an identified reconstructed synapse of Lymnaea stagnalisJournal of Anesthesia, 2011
- Clinical dose of lidocaine destroys the cell membrane and induces both necrosis and apoptosis in an identified Lymnaea neuronJournal of Anesthesia, 2011
- Prolotherapy in Primary Care PracticePrimary Care: Clinics in Office Practice, 2010
- Apoptosis and Mitochondrial Dysfunction in Human Chondrocytes Following Exposure to Lidocaine, Bupivacaine, and RopivacaineJournal of Bone and Joint Surgery, 2010
- High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2Molecular and Cellular Biochemistry, 2007
- Efficacy of dextrose prolotherapy in elite male kicking-sport athletes with chronic groin painArchives of Physical Medicine and Rehabilitation, 2005
- MAPK signal pathways in the regulation of cell proliferation in mammalian cellsCell Research, 2002